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Background: Haemolytic conditions may contribute to disease pathogenesis and severe clinical manifestations
through the liberation of free haemoglobin (Hb) and production of toxic free haem. Thus, free Hb and haem
should be associated with altered MetHb and COHb levels in malaria as in other conditions.
Methods: This study comprises data collected at three different sites: (i) a retrospective analysis of the first
arterial blood gas result (ABGS) of any patient during 2010 at the University Hospital in Lisbon; (ii) a retrospective
analysis of ABGS from patients with severe malaria admitted to the intensive care unit in Berlin, Germany; and
(iii) a prospective study of non-invasive MetHb measurements in children with and without malaria in
Lambaréné, Gabon.
Results: In Lisbon, the mean MetHb level was 1.4% (SD: 0.5) in a total of 17,834 ABGS. Only 11 of 98 samples with a
MetHb level of >3.0 referred to infections. COHb levels showed no particular association with clinical conditions,
including sepsis. In 13 patients with severe malaria in Berlin, the mean MetHb levels on admission was 1.29%, with
1.36% for cerebral malaria and 1.14% for non-cerebral malaria (P > 0.05). All COHb measurements were below 2.3%.
In Lambaréné, Gabon, 132 healthy children had a mean MetHb level of 1.57%, as compared to 150 children with
malaria, with a value of 1.77% and 2.05% in uncomplicated and complicated cases, respectively (P < 0.01).
Conclusions: The data appears consistent with the methaemoglobin/haem hypothesis in malaria and sepsis
pathogenesis. However, although MetHb was significantly different between healthy controls and children with
malaria in Africa, the difference was rather small, also when compared to previous studies. Still, non-invasive bedside
MetHb testing may warrant further evaluation as it could be a simple adjuvant tool for prognosis in resource poor
settings.Background
Conditions which cause haemolysis and lead to free
haemoglobin (Hb) appear to contribute to disease patho-
genesis and often severe clinical manifestations, such as
renal impairment, vascular disease or inflammation [1].
One proposed mechanism is the liberation of haem from
Hb with its pro-inflammatory effects [2,3]. The proposed
chain of events starts with the lysis of red blood cells
(RBC) and the production of free haemoglobin (Hb)* Correspondence: M.P.Grobusch@amc.uva.nl
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article, unless otherwise stated.which is oxidized to methaemoglobin (MetHb), liberating
the haem group [4]. Haem oxygenase (HO-1) degrades
haem, producing biliverdin, iron and carbon monoxide
(CO) [5] and subsequently carboxyhaemoglobin (COHb)
[6]. While it has been suggested that the liberation of
haem is pro-inflammatory and thus contributes to severe
forms of infections, such as sepsis or malaria, HO-1 and
CO are postulated to have protective effects, as hinted at
by the beneficial effects observed after administration of
CO in mouse models of these conditions [7,8]. In this
context it is noteworthy that increased HO-1 expression
in man was reported in fatal falciparum malaria and sepsis
[9]. Free haem is not limited to infections and has also
been associated with non-infectious haemolytic condi-
tions, such as sickle cell disease [10].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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free Hb and haem, as well as the increase of HO-1 should
be associated with altered MetHb and COHb levels in
malaria and possibly other severe infections. Indeed, in an
experimental cerebral malaria model in rodents, MetHb
levels were significantly raised as compared to non-infected
controls [7]. Although unexpectedly, no differences were
reported for COHb levels [11].
Patients with overt haemolysis as in sickle cell crisis
often have noticeably increased MetHb and COHb levels
[12,13]. Three studies in malaria reported different MetHb
levels as compared to controls, although the magnitude
of the difference as well as the observed values varied
several-fold between studies [14-16]. The picture for
COHb appears even more complex. Markedly raised
levels were reported in Kenyan children and Indonesian
adults, with mean values in the order of 4-5% and 7-10%,
respectively; two to three-fold the control value [16,17].
Puzzlingly, in Kenya, all children admitted to hospital had
raised COHb levels, independent of their underlying dis-
ease [17]. As pointed out in these studies, COHb levels
may be strongly influenced by external sources of CO, for
example cooking fires or cigarette smoke, while MetHb
levels ought to reflect closer the underlying haemolytic
process [4].
MetHb and COHb are usually invasive tests, which re-
quire a blood sample. In affluent countries they are deter-
mined as part of the arterial blood gas analysis (ABGS),
using sophisticated instruments, often not available in
malaria endemic areas. A new type of pulse oximeter, the
RAD-57™ (Masimo Inc., Irvine/CA/USA) allows to meas-
ure MetHb non-invasively (Figure 1) if appropriate fingerFigure 1 Methaemoglobin measurement with the pulse
oximeter. RAD-57™ “Rainbow”® Pulse oximeter (Masimo) with
fingerprobe for MetHb detection applied to the third finger of the
right hand of a child (healthy control) during measurement. The
finger/hand is held to reduce movement for 45–60 seconds and the
procedure is non-invasive and painless.probes are used [18]. Thus, the usefulness of measuring
haemoglobin subtypes in malaria can be revisited.
The objective of the study was to establish values for
MetHb and COHb, measured invasively, in (i) a general
patient population of a European tertiary care hospital
(Lisbon) with or without evidence of infection and/or
sepsis and (ii) in a retrospective cohort of patients with se-
vere malaria in Europe (Berlin). The Lisbon data served to
establish baseline values for MetHb and COHb, while the
Berlin study served to determine which would be best pa-
rameters to be measured in Gabon, based on the observed
alterations in severe malaria. Based on these results, (iii)
the study prospectively investigated the usefulness of non-
invasive measurement of MetHb in Gabonese children
with malaria.
Methods
This study comprises data collected during three studies
at three different sites: (i) a retrospective analysis of all
arterial blood gas results performed during 2010 at the
University Hospital in Lisbon and for which MetHb and
COHb was also measured, (ii) a retrospective analysis of
ABGS from patients admitted to the intensive care unit
at Charité University Medical Center in Berlin, Germany,
with severe malaria in the years from 2003 to 2007, and
(iii) a prospective study of MetHb measurements in
children with and without malaria at CERMEL/HAS,
Lambaréné, Gabon during the year 2012. Each part of
the study was approved by the ethics committee at the
respective study site in Lisbon, Berlin and Lambaréné.
In Lambaréné informed consent was obtained from
parents/guardians prior to inclusion.
In Lisbon, data from all those arterial blood gas ana-
lyses for which MetHb and COHb results were also
available were obtained from the Laboratory Informa-
tion System (LIS) for a one-year period. Only the first
result in a series of results of the same episode was used,
thought to represent the result on presentation. Infor-
mation on the location/department of request and clin-
ical information which accompanied the request were
recorded. Arterial blood gases were analysed on a ABL
800 FLEX (Radiometer, Copenhagen, Denmark) as de-
scribed by the manufacturer. All results were analysed
to establish associations between MetHb, COHb and
clinical information.
In Berlin, results were retrieved retrospectively for a
cohort of patients with severe malaria who had been cared
for on the Intensive Care Unit (ICU). MetHb and COHb
mean values for the first day on ICU and in the clinical
course were analysed for differences between groups.
Arterial blood gases were determined on a ABL 800 Flex
instrument (Radiometer, Copenhagen).
At the Hospital Albert Schweitzer in Lambaréné (HAS),
children suffering either from non-complicated malaria or
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Control subjects from the local kindergarden of the HAS
and a primary school in town were invited to participate.
Children with sickle cell disease were excluded. Sickle cell
status was determined by electrophoresis. MetHb levels
were measured non-invasively using a RAD-57™, pulse
oximeter with a pediatric MetHb rainbow® finger probe
(Masimo, Irvine CA, USA). The measurement involves
placing the finger probe on the third finger and immobil-
izing the hand during the measurement for about 45–60
seconds (Figure 1). Each measurement was obtained in
triplicate and the mean value was calculated for further
analysis. Blood samples were only obtained from children
with malaria. Haemoglobin values were obtained (ABX
pentra 60, Horiba Medical, Montpellier/France) and mal-
aria diagnosis and parasitaemia were established in thick
films using the Lambaréné method for reading slides [19].
Data was analysed in SPSS version 15.0 (IBM Corporation,
Armonak, NY, USA). Results were analysed using the
student t-test for unpaired data, the Chi-Square test or
Fisher’s Exact test and differences of p < 0.05 were
considered to be statistically significant.
Results
In Lisbon, 17,834 arterial blood gas results from patients
(50% male/50% female) with a mean age of 61.5 years
(SD: 22.9, range: 1 week – 103 years) were retrieved.
Overall, the mean MetHb level was 1.4% (SD: 0.5, range:
0.1%-13.1%) and the distribution for infectious diseases,
including sepsis are shown in Figure 2. The distributionFigure 2 Methaemoglobin values in an unselected hospital populatio
retrospectively from the laboratory information system for a one year perio
(n = 17,834). Stratified by clinical information accompanying the request int
black line – sepsis (n = 476), dashed line - respiratory infection (n = 2,273), s
haemolytic condition: thin dotted line – sickle cell disease (n = 24). Histogra
percentage in each category. No significant difference (p = 0.63) between nof all infectious categories virtually equals the ‘no infec-
tions’ category. Interestingly, there is no statistically sig-
nificant difference (p = 0.63) between sepsis and absence
of infection. Although the number is very low (n = 24),
the samples with the clinical information ‘sickle cell dis-
ease’ showed higher MetHb levels, as one would expect in
such a haemolytic condition (Figure 2, thin dotted line).
Of 98 samples with a MetHb level of >3.0 only 11 had
infections as per clinical information, eight of them a re-
spiratory tract infection. The correlation between MetHb
and haemoglobin (r = −0.18, P > 0.001) or MetHb and
COHb (r = −0.03, P < 0.001) was low. COHb levels showed
no particular association with clinical conditions, includ-
ing sepsis. The only exception was, unsurprisingly, CO
poisoning/inhalation (Additional file 1).
In Berlin, ABGS from 13 patients who fulfilled the
WHO criteria for severe malaria admitted to the inten-
sive care unit (ICU) were retrospectively retrieved. The
patient’s main characteristics are shown in Table 1,
including clinical information, such as haemolysis. The
distribution of mean values of MetHb on admission and
for the following days in the ICU varied little, as shown
in Figure 3. No single MetHb level above 2% was observed
(Table 1). The mean value of the MetHb levels for all pa-
tients on the day of admission was 1.29% (SD: 0.38); 1.36%
(SD: 0.36) for cerebral malaria and 1.14% (SD:0.45) for
non-cerebral malaria, with no statistically significant dif-
ference. Results for all COHb measurements during their
ICU stay are summarized in Additional file 2 which
shows that all results were below 2.3%, except for onen in Lisbon. Distribution of methaemoglobin values retrieved
d from an unselected population at the University Hospital, Lisbon
o major groups: shaded grey area – no infection (n = 14,062), solid
quare dotted line –other infections (n = 725). As comparison for
m based on 0.1% intervals (bins) of MetHb values. Y-axis represents
o infection with a mean of 1.37% and sepsis with a mean of 1.36%.
Table 1 Characteristics of patients with severe malaria admitted to the ICU in Berlin
Age (y) P.f. (%)* Severe malaria Days (ICU) ABGS (n)** MetHb % range Remarks
52 1.0% CM 4 7 1-1.6 Septic shock
62 0.5% CM, ARDS, ARF 3 4 1.4-1.7 Pneumonia, sepsis
53 16.0% CM, ARF, HP 3 5 0.4-0.6 HIV
62 17.0% CM, ARF, HP 3 7 1.1-1.6 Shock, diarrhoea, UTI
49 8.0% CM, HP 7 23 0.2-1.5
39 12.0% CM, HP 5 7 1.2-1.8 Black water fever, rhabdomyolysis,
39 31.0% CM, HP, ARF 3 7 0.6-1.3 Pancreatitis
46 10.0% CM, HP, ARF 4 14 0.7-1.8 HCV, diarrhoea, haemolytic anaemia
59 15.0% CM, HP, ARF 4 14 0.5-1.3
29 20.0% HP 6 14 0.3-1.9 Anaemia
32 7.0% HP 7 12 0.9-1.2
60 9.5% HP 7 17 1-1.9 Anaemia - Hb 6.6,
28 8.0% HP 3 6 1-1.8 Black water fever
Characteristics of patients admitted to the Intensive Care Unit (ICU) in Berlin with criteria of severe malaria: CM - cerebral malaria, ARF – acute renal failure,
ARDS –acute respiratory distress syndrome, HP – hyperparasitaemia. Therapy with either standard intravenous quinine (Q) or artesunate (AS). * = Plasmodium
falciparum parasitaemia in %; ** = number of measurements of arterial blood gases during ICU stay.
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lytic anaemia (Table 1).
In Lambaréné, Gabon, a total of 282 children were in-
cluded, 132 controls and 150 with malaria. The charac-
teristics of the study population and the mean values for
MetHb are shown in Table 2. The distribution of the
MetHb values are represented in Figure 4. The mean valueFigure 3 Methaemoglobin values in patients with complicated
malaria admitted to an Intensive Care Unit in Berlin.
Methaemoglobin values retrieved retrospectively from patients
admitted with malaria to the Intensive Care Unit at the Charité
University Hospital in Berlin (n = 13). All patients had criteria for
complicated malaria, with 8 patients having cerebral malaria (lines)
and 5 patients having other criteria, as shown in Table 1 (dashed
lines). The mean MetHb values was calculated for each day while
patients were in the ICU and lengths of the lines corresponds to
time in the ICU. Mean value of MetHb levels for the day on
admission was 1.29% (SD: 0.38) for all measurements, and 1.36%
(SD:0.36) for cerebral malaria while it was 1.14% (SD:0.36) for
non-cerebral malaria (NS).for healthy children was 1.57%. It was 1.77% and 2.05% in
children with uncomplicated and complicated malaria,
respectively, which was significantly different (p < 0.01)
from the healthy controls, although the distributions show
some overlap (Figure 4). The correlation coefficient for
parasitaemia and MetHb was 0.09 (Additional file 3),
while for MetHb and Hb it was −0.14 (Additional file 4).
Discussion
The central chain of events in the haemolysis/MetHb/
haem hypothesis [4,7,8] is based on the idea that levels
of all relevant players, including free Hb, MetHb, liber-
ated haem, HO-1 expression, CO and COHb ought to
be increased in haemolytic conditions. Consequently, in
diseases with acute major haemolysis, such as it occurs
in a sickle cell crisis, one would expect to see markedly
raised MetHb and COHb levels. In fact, a Tanzanian study
reported that the highest COHb levels (6.6%) were seen in
sickle cell disease [14]. The data from this study, obtained
in Lisbon, are consistent with this (Figures 1, Additional
file 1); which also confirms the notion that the clinical
information obtained from the laboratory information
system (LIS) was rather correctly and reflected the true
clinical situation, further underlined by the fact that the
highest COHb levels had the coherent clinical information
of CO poisoning.
It should be noted that reference values can vary a lot,
especially for COHb, from 1.5%-3% in non-smokers and
up to 10% in smokers, highlighting the impact that
environmental factors can have on these values [20-22].
Reference values for MetHb are more consistent, usually
with an upper limit of 1%-1.5% [20,23,24]. However, a
recent study reported that reference values for healthy
Table 2 Characteristics of study population in Lambaréné, Gabon
(n) Age, mean (SD) Sex % (M/F) Parasitaemia/μl, median (IQR) MetHb %, mean (SD) MetHb % (range)
Controls 132 4.8 (0.7) 58%/42% - 1.57 (0.27) 0.9-3.4
Uncomplicated malaria 134 4.4 (2.4) 54%/46% 14,214 (84,722) 1.77 (0.31) 0.6-2.8
Complicated malaria* 16 3.4 (1.9) 68%/32% 31,972 (41,300) 2.05 (0.71) 1.3-4.4
*Complicated malaria includes 5 children with cerebral malaria and 11 with severe anaemia.
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than for adults (1.9%-3.8%) illustrating the difficulty to
find clear-cut values [25]. It thus appears doubtful if the
measurement of COHb is a reliable way to assess haem-
olysis and disease severity.
The results obtained in Lisbon show that the distribu-
tion of infectious diseases, including sepsis, is similar to
that seen in all other conditions, both for MetHb as well
as COHb (Figures 1, Additional file 1). This contrast
with reports where larger increases of CO levels were
reported. One study found a median of 14 nmol/μl in 36
sepsis cases as compared to 7.3 nmol/μl in 21 non-sepsis
cases and 2.1 nmol/μl in 12 HC when measured by gas
chromatography in whole blood [26]. Another study from
Indonesia found raised COHb levels in 20 severe sepsisFigure 4 Methaemoglobin values in children with malaria and health
with the pulse oximeter in children in Lambaréné, Gabon (Figure 1). Bars w
bars children with uncomplicated malaria (n = 134) and black bars children
(SD: 0.27) in healthy children. In non-complicated malaria it was 1.77% (SD:
results significantly different from healthy children (p < 0.01). Each results recases (8%) as compared to 36 healthy controls (3.6%) [16].
Contrary to this, the results presented here appear to be
more in line with a study of 5,322 ABGS measurements in
183 critically ill patients in New York, who reported a
range of results from 0% - 4.8%; and which concluded that
COHb levels did not seem to be clinically useful as marker
of critical illness [27].
Furthermore, the recent study in 117 Indonesian adults
also showed significantly raised COHb levels in moder-
ately and severe malaria, with mean values of 7% and 10%,
respectively, as compared to the 3.6% in healthy controls
(HC). Interestingly, this contrasts with a much larger
study in 1,520 Kenyan children [17]. Although they found
increased COHb levels in malaria as well, with signifi-
cantly different mean values in severe forms (4.3%) asy controls in Lambaréné, Gabon. Methemglobin values measured
ith light upper diagonal pattern show healthy controls (n = 132), grey
with complicated malaria (n = 16). Mean MetHb levels were 1.57%
0.31) while it was 2.05% (SD:0.71) for complicated malaria; with both
presents the mean of triplicate measurements.
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was much smaller with 0.3%. Surprisingly, all children
who presented to hospital had raised COHb levels inde-
pendent of the type of disease, with mean values ranging
from 3.5% in burns to 6.6% in sickle cell disease, values
which reportedly were not significantly different from
malaria. In the study presented here no compelling differ-
ences for COHb were observed in the general patient
population in Lisbon or the severe malaria cases in Berlin,
the reason why this measurement was not performed in
Gabon. Certainly, COHb levels may be influenced by
many environmental factors, like smoke exposure or
air-pollution [28], making them less suitable as a marker
of haemolysis. Furthermore, although the non-invasive
measurement with the RAD-57™ appears to detect alter-
ations of COHb reasonably well [29,30], one study
alerted that it may not be interchangeable with standard
laboratory measurements [31].
MetHb in malaria
As a baseline, in Lisbon MetHb levels were very similar
between any infection and other clinical conditions,
while only sickle cell disease showed a clear increase
(Figure 2). Although some MetHb results were raised
above 1.5%, only 98 samples (0.05% of all) were raised
above 3%, with 11 samples having infections as clinical
information.
Several studies have investigated MetHb levels in mal-
aria, yet the results are often discrepant with regards to
the absolute values as well as the magnitude of differ-
ence between the studied disease categories and HC.
One study in 132 Tanzanian children reported signifi-
cantly increased MetHb levels in uncomplicated and
complicated malaria, with mean values ranging from
4.1%-5.8% as compared to HC with a mean MetHb level
of 2%. However, no significant difference between the
various forms of malaria were found [14]. In another
study in adult Indonesians, median MetHb levels were
only slightly increased with values of 0.8% in non-severe
malaria and 1.2% in severe malaria as compared to 0.6%
in HC [16]. The authors of this study suggest that differ-
ent Hb levels in their study population as compared to
the Tanzanian children might explain the discrepant
observations. However, the mean Hb was 12.9 g/dL in
the Indonesian HC and 11.1 g/dL in the Tanzanian HC,
yet the MetHb levels observed in Indonesia were very
different from those observed in Tanzania. On the other
hand, in the Indonesian adults, Hb levels differed only
by 2.3 g/dL between HC and patients with severe mal-
aria, while in Tanzania the value was 4.7-6,5 g/dL lower
in the three severe malaria groups as compared to HC.
In fact, while the Tanzanian study reported a correlation
of Hb and MetHb values, this was not observed in
Indonesia.In this present study, MetHb differed significantly be-
tween children with malaria (complicated or uncompli-
cated) as compared to HC. However the magnitude of this
difference was modest, with some overlap of values in
both categories (Figure 4). The correlation of MetHb with
parasitaemia or anaemia was also rather low, although the
Hb values ranged from 3 g/dL to 13 g/dL (Additional
file 4). In the Berlin sub-study, no significant differences
were observed between cerebral malaria versus other
manifestations of severity, although the small sample size
is clearly a limitation.
Thus, the results presented here appear to be more in
line with two studies in Nigeria which reported more
modest increases in MetHb levels in malaria: one study
in 228 blood donors found a significantly higher MetHb
level in Plasmodium falciparum positive individuals with
a mean of 2.7% as compared to negative controls, with a
mean of 2% [15] while another study in children showed
raised MetHb levels in malaria (3.2%) as compared to no
malaria (1.5%) [32].
The presented results still appear consistent with the
haemolysis/methaemoglobin/haem hypothesis, and do not
provide data to falsify this hypothesis [4]. Yet, the magni-
tude of the observed changes in MetHb levels are very
discrete and observed values show a large overlap between
groups (Figures 3 and 4). In fact, the difference is so
discrete that one wonders if it is enough to serve as a
convincing biological explanation for the pathogenesis in
uncomplicated and complicated malaria according to this
hypothesis. Interestingly, correlations between MetHb and
Hb as well as parasitaemia were very low (Additional files
3 and 4). This could be explained by the fact that the Hb
values rather reflected prior anaemia rather than an acute
haemolytic event. Concerning parasites, it is more likely
that MetHb levels reflect total parasite burden rather than
parasitaemia, which is thought to be closer correlated with
disease severity [33]. Still correlation coefficients in both
situations were close to zero.
However, the non-invasive measurement was rapid
and easy to perform and studies have confirmed that
the method appears to be reliable as a screening tool for
measuring MetHb and COHb [29,30,34]. Thus, apart
from testing the haemolysis/methaemoglobin/haem hy-
pothesis, further studies in different populations might
be useful to assess if the non-invasive measurement of
MetHb might not be an adjuvant tool for prognosis
determination in resource-poor settings.
Conclusions
Data from this study still appear to be consistent with
the central chain of events in the haemolysis/MetHb/
haem hypothesis, and they do not provide evidence to
refute this hypothesis. However, the results show that
MetHb and CO-Hb levels in infectious diseases, including
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medical conditions, both for MetHb as well as COHb.
With regard to malaria, although MetHb is significantly
different between healthy control and uncomplicated or
complicated cases in African children, the magnitude of
the difference is very discrete. Nevertheless, the simplicity
of the non-invasive measurement makes bedside MetHb
testing a simple option. The current study was not
designed to address if this measurement might be valuable
adjuvant tool for prognosis determination in resource
poor settings, an issue to be addressed in future studies.
Additional files
Additional file 1: COHb values in an unselected hospital population
in Lisbon. Distribution of Carboxyhaemoglobin values retrieved
retrospectively from the laboratory information system for a one year
period from an unselected population at the University Hospital, Lisbon
(n = 17,720). Stratified by clinical information accompanying the request
into major groups.
Additional file 2: COHb in patients with complicated malaria
admitted to an Intensive Care Unit in Berlin. Carboxyhaemoglobin
values retrieved retrospectively from patients admitted with malaria to
the Intensive Care Unit at the Charité University Hospital in Berlin (n = 13).
All patients had criteria for complicated malaria as defined by the WHO,
with eight patients having cerebral malaria (lines) and five patients
having other criteria, as shown in Table 1 (dashed lines).
Additional file 3: Correlation of MetHb and parasitaemia levels in
children with malaria in Lambaréné, Gabon. Dot plot of MetHb
(Y-axis) versus parasitaemia (parasites/μl) (x-axis).
Additional file 4: Correlation of MetHb and Hb levels in children
with malaria in Lambaréné, Gabon. Dot plot of MetHb (Y-axis) versus
Hb (g/dL) (x-axis).
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